The news: UnitedHealth beat Q1 estimates and raised full-year guidance.

• Q1 revenues were $111.7 billion, up from $109.6 billion a year earlier.
• Adjusted net earnings were $7.23 per share, topping even the highest analyst estimate, per a Bloomberg poll.
• Q1 net income was $6.28 billion, which also surpassed analyst expectations.
• The company raised its annual adjusted earnings guidance by 50 cents a share.

Why it matters: The healthcare giant is mounting a financial rebound after a steep 2025 slump that slashed profits and wiped out hundreds of billions in market value. The downturn was driven largely by UnitedHealth’s struggle to control medical costs, as members—especially seniors and patients with complex conditions—used more care than the company anticipated. Investor confidence was further rattled after the Justice Department disclosed criminal and civil probes into the company’s insurance and billing practices.

UnitedHealth is prioritizing profitability over scale, slashing its Medicare Advantage (MA) enrollees by 10% and tightening cost controls to drive a significant year-over-year margin recovery. The company shed 965,000 Medicare Advantage (MA) members and 220,000 Medicaid members in Q1 2026. The MA losses represent roughly a 10% decline, attributed to UnitedHealth pruning higher-cost (e.g., older and sicker patients) enrollees. At the same time, less generous government payments to MA plans—UnitedHealth is the biggest one—have made membership growth in the program less attractive for insurers.

UnitedHealth’s medical loss ratio (MLR), which measures the percentage of insurance premium revenue an insurer spends on medical claims, dropped from 84.8% to 83.9% YoY—a sign of charging higher premiums and more effective medical cost control. A lower MLR means more money retained by the insurer.

UnitedHealth is also turning to AI to reduce administrative burdens and drive cost savings across the business. Much of the benefit is expected from its planned $1.5 billion investment in AI initiatives in 2026, targeting a 2:1 return on internal use cases.

Implications for health insurers: UnitedHealth is no longer the fast-growing company it once was, and is now focused on modest margin recovery, reining in medical costs by exiting unprofitable insurance markets, while investing heavily in AI to drive operational efficiencies, including for prior authorizations. It’s a strategic shift for the company, but one likely to satisfy investors for now (shares of UnitedHealth are up ~8% today at the time of writing) as long as the DOJ investigations and tighter congressional and regulatory scrutiny of the Big 3 pharmacy benefit managers don’t force material changes to its business. And as the largest healthcare entity in the US, it also foreshadows the 2026 outlook for other vertically integrated players with upcoming earnings—offering a playbook for how publicly traded health insurance conglomerates can reassure Wall Street and navigate ongoing headwinds.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.